Home › Trial NCT00698516
Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer
- Trial IDNCT00698516
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorGlaxoSmithKline
- Enrollment50
- Start date2008-07
- ConditionsRecurrent Small-cell Lung Cancer (SCLC) · Lung Cancer, Small Cell
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.